This industry leading Fellowship provides opportunities to work with seasoned professionals within both Federal Policy & Government Affairs and U.S. Oncology Advocacy and Policy. The Fellow will gain experience working across a matrix team (commercial, medical, HEOR, market access, marketing, and corporate affairs) to gather patient and provider insights, build relationships with relevant third party organizations, and develop advocacy plans that optimize access to high quality cancer care for patients. During this time of continued reform and evolution of the U.S. healthcare system, the Fellow will develop a deep understanding of how healthcare policies are developed and implemented within the US, and how they impact patients, providers, payers, Bristol-Myers Squibb and the biopharmaceutical industry. The Fellow will interact and collaborate with stakeholders across Bristol-Myers Squibb and gain experience in working with patient advocacy organizations, professional organizations, policy stakeholders and other organizations that contribute to the policymaking process and the overall changing healthcare landscape.
Evaluate U.S. healthcare policy proposals and develop related policy analysis to help support policy position development
Support Bristol-Myers Squibb participation in pharmaceutical industry trade associations and other stakeholder efforts on priority public policy issues, including those that affect patient access to innovative medicines, through policy research and other policy analysis
Develop an appreciation and understanding of how public policy issues impact the biopharmaceutical industry and healthcare delivery system
Develop, execute, and monitor strategic national and state advocacy plans that center on empowering patients by providing them with disease state/therapeutic information and ensuring patients have continued access to care
Collaborate across matrix teams (commercial, medical, HEOR, market access, marketing, and corporate affairs) to develop and execute advocacy initiatives
Support commercial, medical, and market access field teams through tool development and national advocacy support
Please consider attending Fellowship Information and Network Day here at Rutgers Ernest Mario School of Pharmacy on November 22nd from 3:30 PM – 8:00 PM so we can visit with you about your interests. For additional information please visit our website: http://pharmafellows.rutgers.edu/applicants/fid.php.
We do not pre-schedule interviews for Midyear, so please do not request an interview via this website. Your emails will not be reviewed.
We will be scheduling interviews starting at 10 AM on December 7th. Prior to scheduling an interview you will need to view the Fellowship information video
Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters. The following people have been designated to handle inquiries regarding the nondiscrimination policies: Judy Ryan, Universitywide Title IX Coordinator, Office of Enterprise Risk Management, Ethics, and Compliance (732-235-5304, email@example.com); and Lisa Grosskreutz, Director, Office of Employment Equity, University Human Resources (848-932-3980, firstname.lastname@example.org). For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or OCR.NewYork@ed.gov.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.